{
  "feature_means": {
    "prediction_value": 0.531270358306189,
    "confidence_score": 0.7927687296416938,
    "model_auc": 0.835114006514658,
    "treatment_effect_estimate": 0.6025407166123778,
    "heterogeneous_effect": 0.5611726384364821
  },
  "feature_stds": {
    "prediction_value": 0.2822755633802377,
    "confidence_score": 0.10911767218800174,
    "model_auc": 0.050607740063217076,
    "treatment_effect_estimate": 0.1739446375761725,
    "heterogeneous_effect": 0.19634923558097722
  },
  "feature_mins": {
    "prediction_value": 0.0,
    "confidence_score": 0.6,
    "model_auc": 0.75,
    "treatment_effect_estimate": 0.3,
    "heterogeneous_effect": 0.2
  },
  "feature_maxs": {
    "prediction_value": 1.0,
    "confidence_score": 0.98,
    "model_auc": 0.92,
    "treatment_effect_estimate": 0.9,
    "heterogeneous_effect": 0.89
  },
  "categorical_encodings": {
    "brands": [
      "Remibrutinib",
      "Fabhalta",
      "Kisqali"
    ],
    "regions": [
      "midwest",
      "west",
      "northeast",
      "south"
    ],
    "journey_stages": [
      "diagnosis",
      "treatment_switch",
      "maintenance",
      "treatment_optimization",
      "initial_treatment"
    ]
  },
  "computed_on_split": "train",
  "computed_timestamp": "2025-11-27T13:02:32.031502"
}